Want to join the conversation?
Based on strong 3Q15 results and continuing momentum in the first half of the year, $AET said it is raising its FY15 operating earnings per share guidance to $7.45-7.55 per share from the previously projected guidance of $7.40 per earning per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.